Diabetes Cure News Type 1

Diabetes Cure News!

Johnson & Johnson is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix and essentially cure the life-threatening hormonal disorder type 1 diabetes.

ViaCyte has already begun testing the device in a small number of diabetic patients. If it works as well in patients as it has in animals, it would amount to a cure, ending the need for frequent insulin injections and blood sugar testing. Watch the FOX5 news report above!

Read more about stem cells technology by ViaCyte.

Add Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.